Similar articles

• Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, alpha-dimethyl-m-tyramine (H 77-77) in rats.

  Lassen JB. Lassen JB. Psychopharmacologia. 1974;37(4):331-40. doi: 10.1007/BF00428919. Psychopharmacologia. 1974. PMID: 4136728 No abstract available.
• Inhibition of 4,alpha-dimethyl-m-tyramine (H 77/77)-induced hypermotility in rats by single and repeated administration of chloropromazine, haloperidol, clozapine and thioridazine.

  Buus Lassen J. Buus Lassen J. Psychopharmacologia. 1975 Jul 23;43(1):25-9. doi: 10.1007/BF00437610. Psychopharmacologia. 1975. PMID: 51502
• Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.

  Caille D, Bergis OE, Fankhauser C, Gardes A, Adam R, Charieras T, Grosset A, Rovei V, Jarreau FX. Caille D, et al. J Pharmacol Exp Ther. 1996 Apr;277(1):265-77. J Pharmacol Exp Ther. 1996. PMID: 8613929
• Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.

  Youdim MB, Weinstock M. Youdim MB, et al. Neurotoxicology. 2004 Jan;25(1-2):243-50. doi: 10.1016/S0161-813X(03)00103-7. Neurotoxicology. 2004. PMID: 14697899 Review.
• Monoamine oxidase inhibition.

  Tipton KF. Tipton KF. Biochem Soc Trans. 1994 Aug;22(3):764-8. doi: 10.1042/bst0220764. Biochem Soc Trans. 1994. PMID: 7821681 Review. No abstract available.